Personalis, Inc. to Present at Biomarkers Week Online 2021
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will present at Biomarkers Week Online 2021.
The presentation, titled “ImmunoID NeXT Platform® for comprehensive tumor immunogenomics and advanced biomarker discovery,” will describe the Personalis universal cancer immunogenomics platform, ImmunoID NeXT™. Erin Newburn, MS, PhD, will present for Personalis. Dr. Newburn will provide an overview of the platform, which combines highly sensitive, exome-scale DNA and RNA sequencing with advanced analytics to provide a multidimensional view of the tumor and the tumor microenvironment (TME) from a single sample preparation. Dr. Newburn will review a case study in a cohort of 51 late-stage melanoma patients that demonstrates how the integration of neoantigen burden, HLA LOH, and Antigen Presentation Machinery (APM) mutational data formed a composite biomarker that more accurately predicted response to checkpoint blockade than other markers. Additionally, Dr. Newburn will highlight our NeXT Liquid Biopsy™, an exome-wide liquid biopsy approach combined with ImmunoID NeXT, to further explore critical areas of tumor biology.
ImmunoID NeXT is the first platform to enable comprehensive analysis of both a tumor and its immune microenvironment from a single sample. The ImmunoID NeXT Platform can be used to investigate the key tumor- and immune-related areas of cancer biology, consolidating multiple oncology biomarker assays into one and maximizing the biological information that can be generated from a precious tumor specimen.
Personalis is a co-sponsor of Biomarkers Week and will have representatives available to answer questions about the company’s cancer immunogenomics capabilities.
About Personalis, Inc.
Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency, and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA MVP. In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue and matched blood sample. The Personalis Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited. For more information, please visit www.personalis.com and follow Personalis on Twitter (@PersonalisInc).
All statements in this press release that are not historical are “forward-looking statements” within the meaning of U.S. securities laws, including statements relating to attributes or advantages of the Personalis NeXT Platform, Personalis’ business opportunities, leadership, plans, vision or growth, or other future events. Such forward-looking statements involve risks and uncertainties, including those related to the COVID-19 pandemic, that could cause actual results to differ materially from any anticipated results or expectations expressed or implied by such statements. Factors that could materially affect actual results can be found in Personalis’ filings with the U.S. Securities and Exchange Commission, including Personalis’ most recent reports on Forms 8-K, 10-K and 10-Q, and include those listed under the caption “Risk Factors.” Personalis disclaims any obligation to update such forward-looking statements.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Investor Relations Contact for Personalis:
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Bentley Systems Completes Acquisition of Seequent, Global Leader in 3D Modeling Software for the Geosciences17.6.2021 23:05:00 EEST | Press release
Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced the completion of its acquisition of Seequent Holdings Limited, for approximately $900 million in cash (for a debt free business and subject to final working capital adjustments) plus 3,141,342 BSY Class B shares. When announcing its second quarter 2021 operating results (scheduled for August 10, 2021) Bentley Systems will update its full‑year 2021 financial outlook, reflecting the inclusion of Seequent. About Bentley Systems Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry‑leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campus
Pattern Computer Develops Accurate 15-Second COVID-19 Test17.6.2021 23:03:00 EEST | Press release
Pattern Computer,® Inc. (PCI) has developed a novel test for near real-time (15 sec) diagnosis of SARS-CoV-2 infections. In contrast with widely used antibody and PCR tests, which take at least 15 minutes to produce results, and require scarce reagents to process, the newly developed PCI method enables high-volume throughput of tests without requiring chemical reagents at difficult to service locations, such as company entrances, event venues, court houses, state and federal facilities, TSA screening areas and ports of entry. “Having a simple, fast, easy to administer, high accuracy COVID-19 test will be critical for TSA and the airline carriers to increase passenger safety and confidence, as carriers deal with rising passenger loads and increased health security requirements,” said Bob Edwards, former CIO for United Airlines. “Pattern Computer’s new system appears to meet that need.” Developed using the Pattern Discovery Engine™ (PDE) comprised of proprietary software methods and spec
Lunaphore Appoints Dr. Carlo Bifulco to Scientific Advisory Board17.6.2021 18:00:00 EEST | Press release
Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment for cancer research, announces the appointment of Dr. Carlo Bifulco, an expert in Translational Molecular Pathology and Pathology Informatics, to its Scientific Advisory Board (SAB) to provide strategic advisory support to the company’s scientific activities and product portfolio development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210617005459/en/ Dr. Carlo Bifulco (Photo: Business Wire) Dr. Bifulco is a Surgical Pathologist with additional fellowship subspecialty training, expertise, and board certification in Molecular Genetic Pathology and Hematopathology. Dr. Bifulco serves on the Global Colon Cancer Immunoscore Task Force led by the Society for Immunotherapy of Cancer (SITC) and is co-Chair of the SITC Pathology Task convened to establish multiplexed immunohistochemistry/immunofluorescence (mIHC/IF) standards
Andersen Global Expands Into Four Caribbean Countries With CATC-HCC17.6.2021 16:30:00 EEST | Press release
Andersen Global enters into a Collaboration Agreement with tax and advisory firm CATC-HCC, bolstering its presence in the Caribbean with four additional locations in Aruba, Bonaire, Curaçao and St. Maarten. The CATC-HCC group of companies is led by Office Managing Partners Mireille de Miranda, Reint Roossien, Norman Henriquez and Jans Stam van Malsen, operating with more than 65 professionals. Headquartered in Aruba, the full-service firm provides tax and advisory services to individuals and businesses. “Our vision remains to be a benchmark organization and leading firm for financial business support in the region,” Mireille said. “Our clients operate both locally and in multiple jurisdictions, and collaborating with Andersen Global further supplements our service offerings and ability to deliver seamless, best-in-class services globally as we continue to create value for our clients.” “CATC-HCC provides broad regional and synergistic coverage as we continue to expand in the Caribbean,
Glamhive & Mary Kay Global Design Studio Announce First-Ever Global TikTok Reality Show Based on Style —Step & Repeat— Showcasing Talent in Wardrobe, Makeup & Hair from TikTok Users Worldwide17.6.2021 16:17:00 EEST | Press release
Today, Glamhive and Mary Kay Global Design Studio announce Step & Repeat, the first-ever style show launching on TikTok. Step & Repeat is a five-week style competition and mentorship program where wardrobe stylists, makeup artists, and hair stylists worldwide compete in the fast-paced environment of TikTok to drive their business success. The international competition is open to all and goes live on June 22 on TikTok. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210617005552/en/ CEO & Founder of Glamhive (Step & Repeat Co-Creator) Stephanie Sprangers (Photo: Mary Kay Inc.) TikTok's community has been growing at an incredible pace since the start of the pandemic, and unique new talents are being discovered daily on the platform. The most ambitious parlay their popularity into business opportunities, transforming entertainment into entrepreneurship, a mindset supported and lauded both by Glamhive and Mary Kay, particularly n
Weta Digital Partners With Autodesk to Offer Next Generation Creative Cloud Production Pipeline17.6.2021 16:00:00 EEST | Press release
Weta Digital, one of the world’s premiere visual effects studios, has partnered with global media and entertainment software provider, Autodesk, Inc. (NASDAQ: ADSK), to launch WetaM - a ground breaking product offering that provides tools designed and developed by Weta Digital, fully embedded in Autodesk Maya. Weta Digital has won 13 Academy Sci-tech Awards for its tools that helped artists produce some of the most successful film and TV series in the world, including “The Lord of the Rings,” “Avatar,” “Game of Thrones,” and “Planet of the Apes,” to name a few. Weta intends to rollout WetaM as a private beta in Q4. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210617005301/en/ Planet of the Apes Copyright:© 2017 Twentieth Century Fox Film Corporation (Photo: Business Wire) WetaM productizes Weta’s unique set of proprietary VFX tools for artists built on Maya’s open API, and will be commercialized by Weta Digital as a subscr
Hologic Completes Acquisition of Mobidiag17.6.2021 15:45:00 EEST | Press release
Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced acquisition of Mobidiag Oy, an innovator in near-patient, acute care molecular diagnostic testing, for an enterprise value of approximately $808 million. “Closing the acquisition of Mobidiag enables us to become a broader, more diversified global diagnostics leader,” said Jan Verstreken, group president, international at Hologic. “Together, we can accelerate development and adoption of Mobidiag’s innovative products globally and drive Hologic’s growth.” Mobidiag provides near-patient, molecular diagnostic instruments and tests for acute care conditions including gastrointestinal and respiratory infections, antimicrobial resistance management, and healthcare associated infections. Its Amplidiag and Novodiag testing platforms deliver results in 50 minutes to two hours. The Novodiag platform combines real-time PCR and microarray capabilities to provide high-level multiplexing. Multiplex
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom